Rates and predictors of genital warts burden in the czech population

International Journal of Infectious Diseases

Volumn 35, Issue , 2015, Pages 29-33

  Petráš, Marek ^a   Adámková, Věra ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Genital warts; Human papillomavirus; Incidence; Prevalence; Risk predictors

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CONDYLOMA ACUMINATUM; CROSS-SECTIONAL STUDY; CZECH REPUBLIC; FEMALE; HUMAN; INCIDENCE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PREVALENCE; RISK FACTOR; SELF REPORT; SEXUALITY; CONDYLOMATA ACUMINATA; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; CONDYLOMATA ACUMINATA; CROSS-SECTIONAL STUDIES; CZECH REPUBLIC; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEXUAL PARTNERS; YOUNG ADULT;

EID: 84928667882     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2015.04.002     Document Type: Article

References (31)

1. Clarke P., Ebel C., Catotti D.N., Stewart S. The psychosocial impact of human papillomavirus infection: implications for health care providers. Int J STD AIDS 1996, 7:197-200.
2. Maw R.D., Reitano M., Roy M. An international survey of patients with genital warts: perceptions regarding treatment and impact on lifestyle. Int J STD AIDS 1998, 9:571-578.
3. Von Krogh G., Lacey C.G., Gross G., Barrasso R., Schneider A. European course 22 on HPV associated pathology: guidelines for primary care physicians for the diagnosis and management of anogenital warts. Sex Transm Infect 2000, 76:162-168.
4. Chuang T.Y., Perry H.O., Kurland L.T., Ilstrup D.M. Condyloma acuminatum in Rochester, Minn., 1950-1978. I. Epidemiology and clinical features. Arch Dermatol 1984, 120:469-475.
5. Kjaer S.K., Lynge E. Incidence, prevalence and time trends of genital HPV infection determined by clinical examination and cytology. IARC Sci Publ 1989, 94:113-124.
6. Becker T.M., Stone K.M., Alexander E.R. Genital human papillomavirus infection. A growing concern. Obstet Gynecol North Am 1987, 14:389-396.
7. Munk C., Svare E.I., Poll P., Bock J.E., Kjær S.K. History of genital warts in 10,838 women 20 to 29 years of age from the general population: risk factors and association with Papanicolaou smear history. Sex Transm Dis 1997, 24:567-572.
8. Khan A., Hussain R., Schofield M. Correlates of sexually transmitted infections in young Australian women. Int J STD AIDS 2005, 16:482-487.
9. Garland S.M., Steben M., Sings H.L., James M., Lu S., Railkar R., et al. Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine. J Infect Dis 2009, 199:805-814.
10. Joura E.A., Giuliano A.R., Iversen O.E., Bouchard C., Mao C., Mehlsen J., et al. A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med 2015, 372:711-723. Broad Spectrum HPV Vaccine Study.
11. Brotherton J.M., Heywood A., Heley S. The incidence of genital warts in Australian women prior to the national vaccination program. Sex Health 2009, 6:178-184.
12. Dinh T.H., Sternberg M., Dunne E.F., Markowitz L.E. Genital warts among 18- to 59-year-olds in the United States, national health and nutrition examination survey, 1999-2004. Sex Transm Dis 2008, 35:357-360.
13. Munk C., Nielsen A., Liaw K.L., Kjaer S.K. Genital warts in men: a large population-based cross-sectional survey of Danish men. Sex Transm Infect 2012, 88:640-644.
14. Kjaer S.K., Tran T.N., Sparen P., Tryggvadottir L., Munk C., Dasbach E., et al. The burden of genital warts: a study of nearly 70,000 women from the general female population in the 4 Nordic countries. J Infect Dis 2007, 196:1447-1454.
15. Fait T., Dvořák V., Skřivánek A., Rokyta Z., Pilka R. Epidemiology of genital warts in female population of Czech Republic. Ceska Gynekol 2012, 77:360-363.
16. Simms I., Fleming D.M., Lowndes C.M., Smith G.E., Chapman R.S. Surveillance of sexually transmitted diseases in general practice: a description of trends in the Royal College of General Practitioners Weekly Returns Service between 1994 and 2001. Int J STD AIDS 2006, 17:693-698.
17. Monsonégo J., Breugelmans J.G., Bouée S., Lafuma A., Bénard S., Rémy V. Anogenital warts incidence, medical management and costs in women consulting gynaecologists in France. Gynecol Obstet Fertil 2007, 35:107-113.
18. Castellsagué X., Cohet C., Puig-Tintoré L.M., et al. Epidemiology and cost of treatment of genital warts in Spain. Eur J Public Health 2009, 19:106-110.
19. Hillemanns P., Breugelmans J.G., Gieseking F., Bénard S., Lamure E., Littlewood K.J., et al. Estimation of the incidence of genital warts and the cost of illness in Germany: a cross-sectional study. BMC Infect Dis 2008, 8:76.
20. Marra F., Ogilvie G., Colley L., Kliewer E., Marra C.A. Epidemiology and costs associated with genital warts in Canada. Sex Transm Infect 2009, 85:111-115.
21. Hoy T., Singhal P.K., Willey V.J., Insinga R.P. Assessing incidence and economic burden of genital warts with data from a US commercially insured population. Curr Med Res Opin 2009, 25:2343-2351.
22. Koshiol J.E., Laurent S.A., Pimenta J.M. Rate and predictors of new genital warts claims and genital warts-related healthcare utilization among privately insured patients in the United States. Sex Transm Dis 2004, 31:748-752.
23. Wen L.M., Estcourt C.S., Simpson J.M., Mindel A. Risk factors for the acquisition of genital warts: are condoms protective?. Sex Transm Infect 1999, 75:312-316.
24. Daling J.R., Sherman K.J., Weiss N.S. Risk factors for condyloma acuminatum in women. Sex Transm Dis 1986, 13:16-18.
25. Wiley D.J., Elashoff D., Masongsong E.V., Harper D.M., Gylys K.H., Silverberg M.J., et al. Smoking enhances risk for new external genital warts in men. Int J Environ Public Health 2009, 6:1215-1234.
26. Hansen B.T., Hagerup-Jenssen M., Kjaer S.K., Munk C., Tryggvadottir L., Sparén P., et al. Association between smoking and genital warts: longitudinal analysis. Sex Transm Infect 2010, 86:258-262.
27. Johnson A.M., Mercer C.H., Erens B., Copas A.J., McManus S., Wellings K., et al. Sexual behaviour in Britain: partnerships, practices, and HIV risk behaviours. Lancet 2001, 358:1835-1842.
28. Ali H., Donovan B., Wand H., Read T.R., Regan D.G., Grulich A.E., et al. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data. BMJ 2013, 346:f2032.
29. Blomberg M., Dehlendorff C., Munk C., Kjaer S.K. Strongly decreased risk of genital warts after vaccination against human papillomavirus: nationwide follow-up of vaccinated and unvaccinated girls in Denmark. Clin Infect Dis 2013, 57:929-934.
30. Mariani L., Vici P., Suligoi B., Checcucci-Lisi G., Drury R. Early direct and indirect impact of quadrivalent HPV (4HPV) vaccine on genital warts: a systematic review. Adv Ther 2015, 32:10-30.
31. Grulich A.E., de Visser R.O., Smith A.M., Rissel C.E., Richters J. Sex in Australia: sexually transmissible infection and blood-borne virus history in a representative sample of adults. Aust N Z J Public Health 2003, 27:234-241.